PetMed Express, Inc. (PETS)’s CEO & President Menderes Akdag Unloaded 10,000 Shares; Glazer Capital Has Upped Its Bard C R (BCR) Position

Glazer Capital Llc increased Bard C R Inc (BCR) stake by 37.33% reported in 2017Q3 SEC filing. Glazer Capital Llc acquired 18,664 shares as Bard C R Inc (BCR)’s stock rose 26.87%. The Glazer Capital Llc holds 68,664 shares with $22.01 million value, up from 50,000 last quarter. Bard C R Inc now has $ valuation. The stock decreased 100.00% or $331.24 during the last trading session, reaching $331.24. About 4.71 million shares traded or Infinity% up from the average. C.R. Bard, Inc. (NYSE:BCR) has risen 40.70% since January 24, 2017 and is uptrending. It has outperformed by 24.00% the S&P500.

Petmed Express Inc CEO & President and an insider Menderes Akdag recently sold 10,000 company shares worth $570,000 at the average stock price which was $57.0. This is not his first insider trade, in the last 30 days, he sold another 40,000 shares worth $2,060,000 USD. This is a major stocks unloading, and one that is unlikely to remain a secret, as it decreased his ownership of the Company to 2.31% market cap, for a total of 470,000 shares. The transaction, dated 24/01/2018, is recorded on a Form 4 that was filed with the U.S. Security & Exchange Commission and is available here.

PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company has market cap of $1000.00 million. The firm markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats to retail customers. It has a 28.88 P/E ratio. It provides non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, thyroid, diabetes, pain medications, antibiotics, and other specialty medications, as well as generic substitutes.

Investors sentiment decreased to 1.38 in 2017 Q3. Its down 0.09, from 1.47 in 2017Q2. It worsened, as 29 investors sold PetMed Express, Inc. shares while 39 reduced holdings. 40 funds opened positions while 54 raised stakes. 19.66 million shares or 24.06% more from 15.85 million shares in 2017Q2 were reported. Lsv Asset Management holds 0% or 19,400 shares in its portfolio. North Star Management holds 78,341 shares or 0.33% of its portfolio. Bnp Paribas Arbitrage has invested 0% of its portfolio in PetMed Express, Inc. (NASDAQ:PETS). Engineers Gate Manager Limited Partnership reported 0.27% in PetMed Express, Inc. (NASDAQ:PETS). 22,600 are owned by Menta Ltd Liability. Lucus Ltd Liability Corp holds 0.49% in PetMed Express, Inc. (NASDAQ:PETS) or 10,441 shares. Swiss Commercial Bank owns 33,800 shares or 0% of their US portfolio. Morgan Stanley accumulated 295,196 shares. State Of Tennessee Treasury Department stated it has 17,924 shares or 0% of all its holdings. C M Bidwell & Assocs Ltd reported 570 shares. Trexquant L P invested in 0.2% or 23,931 shares. D E Shaw And Com invested 0% of its portfolio in PetMed Express, Inc. (NASDAQ:PETS). Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% in PetMed Express, Inc. (NASDAQ:PETS). Tiaa Cref Invest Mngmt Ltd Co holds 0% or 169,442 shares in its portfolio. Sei Invs Company reported 0% of its portfolio in PetMed Express, Inc. (NASDAQ:PETS).

Since August 1, 2017, it had 0 buys, and 4 insider sales for $3.11 million activity. Another trade for 20,000 shares valued at $887,600 was sold by FULGONI GIAN. AKDAG MENDERES also sold $2.06 million worth of PetMed Express, Inc. (NASDAQ:PETS) shares. The insider KORN RONALD J sold 1,000 shares worth $35,570. SCHWEITZER ROBERT C sold $122,950 worth of stock.

The stock decreased 3.08% or $1.559 during the last trading session, reaching $49.101. About 134,303 shares traded. PetMed Express, Inc. (NASDAQ:PETS) has risen 91.46% since January 24, 2017 and is uptrending. It has outperformed by 74.76% the S&P500.

Among 5 analysts covering Petmed Express Inc (NASDAQ:PETS), 2 have Buy rating, 1 Sell and 2 Hold. Therefore 40% are positive. Petmed Express Inc has $61.0 highest and $40.0 lowest target. $50.50’s average target is 2.85% above currents $49.101 stock price. Petmed Express Inc had 10 analyst reports since February 4, 2016 according to SRatingsIntel. The stock of PetMed Express, Inc. (NASDAQ:PETS) earned “Hold” rating by Noble Financial on Friday, October 27. Craig Hallum maintained PetMed Express, Inc. (NASDAQ:PETS) on Monday, August 21 with “Hold” rating. As per Monday, July 24, the company rating was upgraded by Northcoast. The firm has “Buy” rating by Northcoast given on Friday, January 19. The firm earned “Underperform” rating on Thursday, February 4 by Credit Suisse. The company was downgraded on Tuesday, July 11 by Craig Hallum. On Wednesday, January 3 the stock rating was maintained by Northcoast with “Buy”. The rating was maintained by Noble Financial with “Hold” on Wednesday, July 26. On Monday, May 9 the stock rating was upgraded by Craig Hallum to “Hold”. The rating was upgraded by Sidoti to “Buy” on Thursday, August 24.

Since August 10, 2017, it had 0 insider purchases, and 9 insider sales for $50.05 million activity. Shares for $2.70 million were sold by Collins Timothy P on Friday, October 6. 3,344 shares were sold by Barrett David M, worth $1.09M on Monday, October 30. 30,252 C.R. Bard, Inc. (NYSE:BCR) shares with value of $9.68M were sold by Luboff Sharon M. Beasley Jim C also sold $1.13M worth of C.R. Bard, Inc. (NYSE:BCR) on Thursday, December 14. On Friday, October 20 Larson Betty D sold $1.95 million worth of C.R. Bard, Inc. (NYSE:BCR) or 5,906 shares. On Wednesday, October 18 Lupisella Frank Jr sold $2.98 million worth of C.R. Bard, Inc. (NYSE:BCR) or 9,173 shares. Another trade for 23,687 shares valued at $7.55 million was sold by Groetelaars John P.

Among 15 analysts covering CR Bard (NYSE:BCR), 4 have Buy rating, 0 Sell and 11 Hold. Therefore 27% are positive. CR Bard had 32 analyst reports since August 27, 2015 according to SRatingsIntel. The company was upgraded on Thursday, August 27 by Goldman Sachs. As per Thursday, August 31, the company rating was maintained by BMO Capital Markets. Evercore initiated C.R. Bard, Inc. (NYSE:BCR) rating on Thursday, September 15. Evercore has “Buy” rating and $235 target. Morgan Stanley upgraded C.R. Bard, Inc. (NYSE:BCR) rating on Tuesday, January 3. Morgan Stanley has “Overweight” rating and $260 target. The company was maintained on Wednesday, July 27 by Barclays Capital. As per Friday, July 28, the company rating was maintained by Cowen & Co. The firm has “Equal-Weight” rating given on Monday, November 6 by Barclays Capital. The firm has “Neutral” rating by Bank of America given on Friday, July 8. The rating was downgraded by Wells Fargo to “Market Perform” on Wednesday, April 26. The firm earned “Hold” rating on Wednesday, July 27 by Jefferies.

Investors sentiment increased to 0.59 in 2017 Q3. Its up 0.01, from 0.58 in 2017Q2. It increased, as 57 investors sold BCR shares while 239 reduced holdings. 38 funds opened positions while 138 raised stakes. 55.60 million shares or 0.85% more from 55.14 million shares in 2017Q2 were reported. Jpmorgan Chase And holds 542,368 shares or 0.04% of its portfolio. Commonwealth Comml Bank Of Aus stated it has 0.01% in C.R. Bard, Inc. (NYSE:BCR). Neuberger Berman Group Inc Limited Co holds 0.01% or 16,625 shares. Natl Pension invested in 78,048 shares. Associated Banc reported 839 shares stake. Lombard Odier Asset (Switzerland) holds 7,357 shares or 0.23% of its portfolio. Calamos Wealth Management Ltd Liability Corp reported 1,000 shares stake. Churchill Mgmt reported 18,952 shares. Autus Asset Mgmt Limited Liability stated it has 2,750 shares or 0.17% of all its holdings. 12,013 are held by Bowen Hanes & Company. Maverick Cap reported 11,210 shares stake. Daiwa Grp Inc invested in 4,002 shares. Nationwide Fund holds 0.03% or 20,420 shares. Wetherby Asset Mngmt Inc has 2,820 shares for 0.13% of their portfolio. 1,500 are held by Caxton Assocs Ltd Partnership.

Glazer Capital Llc decreased Electrum Spl Acquisition Cor Shs stake by 1.05M shares to 566,915 valued at $5.81 million in 2017Q3. It also reduced Nxp Semiconductors N V (Prn) stake by 4.08 million shares and now owns 148.13 million shares. Double Eagle Acquisition Cor was reduced too.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: